3-(Difluoromethoxy)-2-nitropyridine, 95+%, 100mg

6-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

3a,4,7,7a-Tetrahydroindene (stabilized with BHT)>98.0%(GC)500mL

1-(1-pyrrolidinyl)cyclohexanecarboxylic acid hydrochloride, 95.0%, 25g

tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride, 95.0%, 1g

5-Chloro-2-methylpyridine, 95.0%, 1g

4-Hydroxymethyl-[1,3]dioxolan-2-one, 90.0%, 25g

2-mercapto-5,6-dimethyl-3-phenylthieno[2,3-d]pyrimidin-4(3H)-one, 95.0%, 250mg

2-Quinolinecarboxamide, N-[2-(4,5-dihydro-2-oxazolyl)phenyl]-, 250mg

Bis(4-tert-butylphenyl)amine>90.0%(GC)25g

N-Boc-4-Bromo-2-fluoro-aniline, 97.0%, 100g

(2E)-3-(2,4-dichlorophenyl)-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 2g

(4,4'-Di-tert-butyl-2,2'-bipyridine)bis[3,5-difluoro-2-[5-trifluoromethyl-2-pyridinyl-kappaN)phenyl-kappaC]iridium(III) Hexafluorophosphate>95.0%(HPLC)(qNMR)200mg